| Member |
Title |
| Mr. Matt Bondy Secretary |
Senior Policy Analyst
Policy and Economic Analysis
Patented Medicine Prices Review Board |
| Mr. Nicolas Gagnon |
Government and Stakeholder Relations
Pfizer Canada Inc. |
| Mr. Edward Gudaitis |
General Manager
Gilead Sciences Canada |
| Ms. Irene Klatt |
Vice-President
Canadian Life and Health Insurance Association Inc. |
| Ms. Catherine Lombardo |
Scientific Advisor
Compliance and Enforcement
Patented Medicine Prices Review Board |
| Ms. Lynn Macdonald |
Member of the Operations Committee
Best Medicine Coalition |
| Mr. Steve Morgan |
Professor
Department of Health Care and Epidemiology
University of British Columbia |
| Mr. Bob Nakagawa |
Assistant Deputy Minister
Pharmaceutical Services
Ministry of Health, British Columbia |
| Ms. Claudia Neuber |
Senior Manager
Business Planning and Risk Management
AstraZeneca Canada Inc. |
Ms. Barbara Ouellet
Chairperson |
Executive Director
Patented Medicine Prices Review Board |
| Ms. Laurene Redding |
Novo Nordisk Canada Inc.
BIOTECanada Representative |